CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits: A case report and literature review

Journal of Gastrointestinal Cancer

Volumn 38, Issue 1, 2007, Pages 19-23

  Kircher, Sheetal M ^a   Gurbuxani, Sandeep ^a   Smith, Sonali M ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Alemtuzumab; Celiac disease; EATL (enteropathy associated T cell lymphoma); FDG PET; Therapy

Indexed keywords

ALEMTUZUMAB; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT; CANCER ANTIBODY; CHOP PROTOCOL; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADD ON THERAPY; AGED; ANTIGEN EXPRESSION; ARTICLE; CACHEXIA; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER FATIGUE; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CASE REPORT; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; FLANK PAIN; GASTROSCOPY; HUMAN; INTESTINE CRYPT; INTESTINE PERFORATION; LYMPHADENOPATHY; MALE; METABOLISM; MULTIPLE CYCLE TREATMENT; NAUSEA; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT RESPONSE; VOMITING; WEIGHT REDUCTION; AFRICAN AMERICAN; FATALITY; PATHOPHYSIOLOGY; SCINTISCANNING; T CELL LYMPHOMA;

AFRICAN AMERICANS; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FATAL OUTCOME; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA, T-CELL; MALE; POSITRON-EMISSION TOMOGRAPHY; PREDNISONE; VINCRISTINE;

EID: 59149090323     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-008-9009-z     Document Type: Article

References (15)

1. A Al-Toma WH Verbeek M Hadithi 2007 Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience Gut. 56 1373 1378 (Pubitemid 47517830)
2. A Alaedini PH Green 2005 Narrative review: celiac disease: understanding a complex autoimmune disorder Ann Intern Med. 142 289 298 (Pubitemid 40216246)
3. RP Anderson P Degano AJ Godkin 2000 In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope Nat Med. 6 337 342 (Pubitemid 30148628)
4. BD Cheson B Pfistner ME Juweid 2007 Revised response criteria for malignant lymphoma J Clin Oncol. 25 579 586 (Pubitemid 350002966)
5. S Daum D Weiss M Hummel 2001 Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue Gut. 49 804 812 (Pubitemid 33096038)
6. G Enblad H Hagberg M Erlanson 2004 A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas Blood. 103 2920 2924 (Pubitemid 38451660)
7. A Fasano C Catassi 2001 Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum Gastroenterology. 120 636 651 (Pubitemid 32171637)
8. J Gale PD Simmonds GM Mead 2000 Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center J Clin Oncol. 18 795 803 (Pubitemid 30106610)
9. 18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study J Clin Oncol. 25 3746 3752 (Pubitemid 47372616)
10. PH Green C Cellier 2007 Celiac disease N Engl J Med. 357 1731 1743
11. D Honemann HM Prince RJ Hicks 2005 Enteropathy-associated T-cell lymphoma without a prior diagnosis of coeliac disease: diagnostic dilemmas and management options Ann Hematol. 84 118 121 (Pubitemid 40089769)
12. EC Obermann TC Diss RA Hamoudi 2004 Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma J Pathol. 202 252 262 (Pubitemid 38208664)
13. WH Verbeek CJ Mulder S Zweegman 2006 Alemtuzumab for refractory celiac disease N Engl J Med. 355 1396 1397 author reply 1397 (Pubitemid 44465494)
14. S Vivas JM Ruiz de Morales F Ramos 2006 Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma N Engl J Med. 354 2514 2515 (Pubitemid 43855075)
15. S Wohrer A Chott J Drach 2004 Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma Ann Oncol. 15 1680 1683 (Pubitemid 39562610)